Escherichia coli remains at the forefront of recombinant protein production, owing to its rapid growth, well-characterised genetics and the ease with which it can be genetically manipulated. The ...
Recent concerns that recombinants may arise amongst SARS-CoV-2 viruses are now a reality. Recombinants have been identified between Delta and Omicron and between variants of Omicron itself, namely ...
There has been an increase in the development of coronavirus disease 2019 (COVID-19) vaccines in several countries due to the rapid spread of severe acute respiratory syndrome coronavirus 2 ...
By combining Transformer-based sequence modeling with a novel conditional probability strategy, the approach overcomes ...
A recent study posted to the medRxiv* preprint server predicted the efficacy of the SOBERANA 02 and SOBERANA Plus coronavirus disease 2019 (COVID-19) vaccines in children. Study: Open label phase I/II ...